The increasing complexity of emerging therapies and the need for faster development have led to the adoption of advanced ...

Analyst Colleen M. Kusy of Robert W. Baird reiterated a Buy rating on Spyre Therapeutics (SYRE – Research Report), retaining the price ...

Sangamo Therapeutics shares rose after the company said the outcome of a recent successful interaction with the Food and Drug Administration provided a clear regulatory pathway to accelerated approval ...

This indicates that while drug development has become more complex and expensive ... Yet, the goals of reduced costs and ...

Technologies for the rapid and efficient testing of small molecules and biologics have greatly accelerated drug discovery.

In recent years, the pharmaceutical industry has witnessed significant advancements, driven by technological innovation. One ...

Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025 ...

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

With the perpetual rise of technology and the proliferation of AI, we are moving faster than ever. New inventions have accelerated nearly every aspect of our lives, including medicine. In 2023, the ...

DBV and FDA are in general agreement that the confirmatory study will need to demonstrate the effectiveness of the Viaskin ...